The rising popularity in GLP-1 agonists for metabolic health has led to a debate about delivery methods : skin-applied devices versus tablets . Typically, GLP-1 treatments were only available in oral https://ronaldlcie978079.ltfblog.com/39439314/glp-1-transdermal-delivery-systems-vs-tablets-what-suitable-for-individuals